Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

531 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The clinical impact of using complex molecular profiling strategies in routine oncology practice.
Laes JF, Aftimos P, Barthelemy P, Bellmunt J, Berchem G, Camps C, Peñas RL, Finzel A, García-Foncillas J, Hervonen P, Wahid I, Joensuu T, Kathan L, Kong A, Mackay J, Mikropoulos C, Mokbel K, Mouysset JL, Odarchenko S, Perren TJ, Pienaar R, Regonesi C, Alkhayyat SS, El Kinge AR, Abulkhair O, Galal KM, Ghanem H, El Karak F, Garcia A, Ghitti G, Sadik H. Laes JF, et al. Among authors: bellmunt j. Oncotarget. 2018 Apr 17;9(29):20282-20293. doi: 10.18632/oncotarget.24757. eCollection 2018 Apr 17. Oncotarget. 2018. PMID: 29755651 Free PMC article.
A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive High-Grade Metastatic Urothelial Carcinoma.
Ramírez de Olano A, Bellmunt J, Rodrigo A, Álvarez L, Terrádez A, García-Foncillas J, Laes JF. Ramírez de Olano A, et al. Among authors: bellmunt j. Case Rep Oncol. 2017 Jun 9;10(2):493-500. doi: 10.1159/000477337. eCollection 2017 May-Aug. Case Rep Oncol. 2017. PMID: 28690523 Free PMC article.
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.
Moreira RB, Debiasi M, Francini E, Nuzzo PV, Velasco G, Maluf FC, Fay AP, Bellmunt J, Choueiri TK, Schutz FA. Moreira RB, et al. Among authors: bellmunt j. Oncotarget. 2017 Aug 8;8(48):84572-84578. doi: 10.18632/oncotarget.20028. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137449 Free PMC article. Review.
[Primary non-Hodgkin's lymphoma of the breast].
Vicente P, Bellmunt J, Ruiz-Marcellan C, García A, Rovirosa A, Solé LA. Vicente P, et al. Among authors: bellmunt j. Med Clin (Barc). 1993 Sep 11;101(7):261-3. Med Clin (Barc). 1993. PMID: 7746002 Spanish.
Sunitinib malate in the treatment of urothelial cancer.
Pons F, Bellmunt J. Pons F, et al. Among authors: bellmunt j. Expert Opin Investig Drugs. 2014 Jan;23(1):115-24. doi: 10.1517/13543784.2014.853740. Epub 2013 Nov 4. Expert Opin Investig Drugs. 2014. PMID: 24188025 Review.
New treatment options for metastatic renal cell carcinoma.
Rodriguez-Vida A, Hutson TE, Bellmunt J, Strijbos MH. Rodriguez-Vida A, et al. Among authors: bellmunt j. ESMO Open. 2017 May 9;2(2):e000185. doi: 10.1136/esmoopen-2017-000185. eCollection 2017. ESMO Open. 2017. PMID: 28761748 Free PMC article. Review.
531 results